SIH Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
SIH Partners's NBIX Position: Q3 2026 in Review
SIH Partners increased its Neurocrine Biosciences (NBIX) stake by 1.5% in Q3 2026, buying an estimated $7.56K and bringing the position to 3,130 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #246.
SIH Partners first reported a position in NBIX in Q1 2025 and has held it in 7 quarters since. The position peaked at $831K in Q1 2025. 735 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- SIH Partners held 3,130 shares of Neurocrine Biosciences worth $444K as of Q3 2026.
- SIH Partners bought 47 Neurocrine Biosciences shares in Q3 2026, an estimated $7.56K.
- Neurocrine Biosciences made up ﹤0.01% of SIH Partners's portfolio in Q3 2026, its #246 holding.
- SIH Partners first reported a position in Neurocrine Biosciences in Q1 2025 and has held it in 7 quarters since.
- SIH Partners's Neurocrine Biosciences position peaked at $831K in Q1 2025.
- 735 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on SIH Partners's 13F filing for Q3 2026, filed 16 Nov 2026.